Aldactone Tablets

    Aldactone Tablets

    S3


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Management of edema associated with congestive heart failure, liver cirrhosis, and nephrotic syndrome; treatment of hypertension; treatment of primary hyperaldosteronism.

    Dosage (summary)

    Initial dose for adults is typically 25 mg to 100 mg once daily, adjusted based on clinical response.

    Onset of Action / Duration

    Diuretic effect usually begins within 24 to 48 hours; maximum effect may take several days.

    Special Populations

    • Elderly patients
    • Patients with renal impairment
    • Patients with hepatic impairment

    Pregnancy & Breastfeeding

    Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Spironolactone is excreted in breast milk; caution is advised when administered to nursing mothers.

    Key Drug Interactions

    • Potassium-sparing diuretics may increase the risk of hyperkalemia when used with other potassium-sparing agents.
    • NSAIDs may reduce the diuretic effect of spironolactone.
    • ACE inhibitors and ARBs may increase the risk of hyperkalemia.

    Contraindications

    • Anuria
    • Acute renal insufficiency
    • Hyperkalemia
    • Addison's disease

    Common side effects

    • Hyperkalemia
    • Hypotension
    • Dizziness
    • Gastrointestinal disturbances
    • Gynecomastia

    Counselling Points

    • Monitor potassium levels regularly during treatment.
    • Report any signs of hyperkalemia such as muscle weakness or irregular heartbeat.
    • Take the medication as prescribed and do not discontinue without consulting a healthcare provider.
    • Avoid potassium supplements and high-potassium foods unless directed by a healthcare provider.

    Serious warnings

    • Use with caution in patients with renal impairment.
    • Monitor blood pressure regularly, especially when initiating therapy.
    • Risk of dehydration and electrolyte imbalance; monitor electrolytes periodically.
    Important Disclaimer

    The Aldactone Tablets professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn